Burg G - Search Results

1

MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.

Böni R, Doguoglu A, Burg G, Müller B, Dummer R. Böni R, et al. Among authors: burg g. J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):416-8. doi: 10.1016/s0190-9622(96)90607-6. J Am Acad Dermatol. 1996. PMID: 8784279

2

Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.

Böni R, Huch Böni RA, Steinert H, Dummer R, Burg G, von Schulthess GK. Böni R, et al. Among authors: burg g. Dermatology. 1995;191(2):119-23. doi: 10.1159/000246528. Dermatology. 1995. PMID: 8520057 Clinical Trial.

3

Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma.

Böni R, Heizmann CW, Doguoglu A, Ilg EC, Schäfer BW, Dummer R, Burg G. Böni R, et al. Among authors: burg g. J Cutan Pathol. 1997 Feb;24(2):76-80. doi: 10.1111/j.1600-0560.1997.tb01100.x. J Cutan Pathol. 1997. PMID: 9162739 Clinical Trial.

4

Serum S100--a marker for disease monitoring in metastatic melanoma.

Henze G, Dummer R, Joller-Jemelka HI, Böni R, Burg G. Henze G, et al. Among authors: burg g. Dermatology. 1997;194(3):208-12. doi: 10.1159/000246103. Dermatology. 1997. PMID: 9187834

5

Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.

Böni R, Burg G, Doguoglu A, Ilg EC, Schäfer BW, Müller B, Heizmann CW. Böni R, et al. Among authors: burg g. Br J Dermatol. 1997 Jul;137(1):39-43. Br J Dermatol. 1997. PMID: 9274623

6

Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation.

Böni R, Matt D, Voetmeyer A, Burg G, Zhuang Z. Böni R, et al. Among authors: burg g. J Invest Dermatol. 1998 Mar;110(3):215-7. doi: 10.1046/j.1523-1747.1998.00109.x. J Invest Dermatol. 1998. PMID: 9506438 Free article.

7

c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.

Böni R, Bantschapp O, Müller B, Burg G. Böni R, et al. Among authors: burg g. Dermatology. 1998;196(3):288-91. doi: 10.1159/000017922. Dermatology. 1998. PMID: 9621133

8

TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.

Kamarashev J, Ferrone S, Seifert B, Böni R, Nestle FO, Burg G, Dummer R. Kamarashev J, et al. Among authors: burg g. Int J Cancer. 2001 Jan 20;95(1):23-8. doi: 10.1002/1097-0215(20010120)95:1<23::aid-ijc1004>3.0.co;2-4. Int J Cancer. 2001. PMID: 11241306

9

Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

Dummer R, Bösch U, Panizzon R, Bloch PH, Burg G; Task Force 'Skin Cancer'. Swiss National Program against Cancer. Swiss Cancer League. Dummer R, et al. Among authors: burg g. Dermatology. 2001;203(1):75-80. doi: 10.1159/000051710. Dermatology. 2001. PMID: 11549807

10

Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.

Böni R, Böni RA, Steinert H, Burg G, Buck A, Marincek B, Berthold T, Dummer R, Voellmy D, Ballmer B, et al. Böni R, et al. Among authors: burg g. Br J Dermatol. 1995 Apr;132(4):556-62. doi: 10.1111/j.1365-2133.1995.tb08711.x. Br J Dermatol. 1995. PMID: 7748746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

651 results

Search Page

Filters